Innospec | IOSP - Cash And Equivalent


Innospec reported $289.1M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Akzo Nobel EUR 1.62B 66M Dec/2025
Arkema EUR 2.19B 235M Dec/2025
Arq USD 4.67M 1.9M Mar/2026
Ashland USD 343M 39M Mar/2026
Avient USD 427.6M 82.9M Mar/2026
Balchem USD 72.87M 1.7M Mar/2026
BASF EUR 2.67B 811M Dec/2025
Croda International GBP 157.8M 9M Jun/2025
Evogene USD 5.63M 2.7M Sep/2025
Flotek Industries USD 5.68M 1.07M Mar/2026
FutureFuel USD 85.56M 9.59M Sep/2025
HB Fuller USD 107.21M 15.24M Sep/2025
Huntsman USD 369M 60M Mar/2026
Innospec USD 289.1M 3.4M Mar/2026
Minerals Technologies USD 315.9M 13.1M Mar/2026
NewMarket USD 73.16M 4.44M Mar/2026
Quaker Chemical USD 169.73M 10.1M Mar/2026
Rayonier Advanced Materials USD 67.94M 7.06M Mar/2026
Sensient Technologies USD 38.54M 2.01M Mar/2026
Solvay EUR 486M 50M Mar/2026
Stepan USD 140.78M 8.09M Mar/2026
Total Nigeria NGN 10.18B 7.74B Jun/2024
Valhi USD 193.7M 20.3M Mar/2026